Although CA and I3C are promising anticancer agents for the treatment of cervical cancer, the low cytotoxicity of CA compared to I3C and the fact that CA induces apoptosis via Cas-3 and cell cycle arrest and inhibits cell proliferation and migration at a higher rate than I3C make CA a more promising agent than I3C. This evidence concerns the gene EFS and cervical carcinoma.